Observational studyInternational journal of clinical oncology2025

Real-world adherence to antiemetic guidelines in Japanese patients receiving high or carboplatin-based moderate emetic risk chemotherapy.

Ayako Okuyama et al.PubMed ↗Publisher ↗

No numbers read from the abstract.